Introduction: Amblyopia is an acquired defect of vision caused by abnormal visual experience that occurs during childhood. Since early diagnosis is important in preventing further irreparable effects, the aim of this study was to investigate the outcome of amblyopia screening in children.

Methods: Data from the amblyopia screening program in the Welfare Department of Bandar Abbas during 2011-2012 were used. Suspected cases were referred to specialists in the Optometry clinic for screening purposes. Subsequently, patients who suffered from strabismus, amblyopia, or refractive errors were referred to ophthalmologists. SPSS version16 was used to analyze the data. The significance level was set at P < 0.05.

Results: Of the 16,599 children examined in 2012, 2486 suspected cases of amblyopia were diagnosed and 168 being diagnosed with amblyopia after visit with ophthalmologist. The prevalence rate of amblyopia was 1.01%. In 2011, of 17,733 cases, 2013 children were diagnosed as suspected cases and 171 patients were diagnosed to be amblyopic finally.

Conclusions: The prevalence of amblyopia in this study was 0.96% and 1.01% in years 2011 and 2012 respectively, which was consistent with the results of studies in other countries. By considering the importance of diagnosing the prevalence of amblyopia on time in preschool and in order to prevent children`s low vision or blindness in future, it is essential to increase the quality of the examinations that are conducted by the trainers. 

Key words: Amblyopia, Screening, Strabismus, Refractive errors
» HTML Fulltext    » PDF Fulltext    » doi: 10.14661/2014.906-911
Air Jordan

The  most recent editorial (June 2021)

Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?

An editorial by Dr. Mehrdad Jalalian

Read more.

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.


To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


Our previous editorial (June 2020)

Lessons from COVID-19 pandemic and the Morocco’s success story.

An editorial by Dr. Benksim Abdelhafid (Morocco)

Read more.


The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:

Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: